Q2 2023 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2023-08-11 · accession 0001104659-23-090058
$136.9M
Reported value
10
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 433000106 | HIMS | Hims & Hers Health, Inc. | $35.1M | 25.6% | 3,733,381 | Common | SOLE |
| 88369M101 | — | Theseus Pharmaceuticals, Inc. | $33.5M | 24.4% | 3,585,346 | Common | SOLE |
| 69945Q105 | — | Pardes Biosciences Inc | $19.6M | 14.3% | 10,811,887 | Common | SOLE |
| 00461U105 | ACRS | Aclaris Therapeutics, Inc. | $13.0M | 9.53% | 1,258,243 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $10.8M | 7.90% | 243,513 | Common | SOLE |
| 49705R105 | KNTEUSD | Kinnate Biopharma Inc. | $10.7M | 7.80% | 3,525,957 | Common | SOLE |
| 83444K105 | SLGCUSD | Somalogic, Inc. | $7.9M | 5.74% | 3,403,276 | Common | SOLE |
| 20454B104 | CMPX | Compass Therapeutics, Inc. | $4.2M | 3.08% | 1,324,071 | Common | SOLE |
| 74765K105 | QSI | Quantum Si Inc | $1.7M | 1.21% | 924,404 | Common | SOLE |
| N69605108 | PHVS | Pharvaris N.V. | $516,910 | 0.38% | 34,142 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.